Exploring Novel Hallmark of Aging Targeting Strategies & Defining Quantitative Endpoints to Enhance Translatability & Clinical Success
Welcome to the 6th Age-Related Disease Therapeutics Summit
The Only Industry-Led Event Dedicated to Accelerating the Development of Treatments for Age-Related Diseases
Age-related disease biotechs are set to shine in 2024, building on 2023's milestones:
- Eli Lilly's partnership with BioAge to test muscle rejuvenation therapy
- Chan Zuckerberg Biolabs tapping into immune cell engineering to eradicate age-related diseases
- Hevolution Foundation investing $20 million into Aeovian Therapeutic's efforts to develop Mtorc1 inhibitors to target ag-related diseases
To successfully navigate the volatile market of 2024, rapid proof-of-concept studies and validated clinical endpoints are crucial for funding and pipeline progress.
The 6th Age-Related Disease Therapeutics Summit is reconvening in San Francisco this June, bringing together 60+ experts in aging and longevity, from the likes of Eli Lilly, Takeda, and Turn Biosciences to explore cutting-edge advances in cellular programming, senolytic pathways, and epigenetic effects – all with the goal of accelerating breakthroughs in age-related disease treatments.
Join us to explore biomarkers, navigate regulatory pathways, and foster collaborations for pipeline support and commercialization.
Gain unparalleled competitive intelligence, scientific advancements and form meaningful partnerships with those solving humankind’s fundamental problem.
60+
Attendees
1
Exclusive Workshop Day
20+
Expert Speakers
3
Content Filled Days
World-Class Speaker Faculty Includes:
Previously Attending Companies Include:
Hear From Your Peers Why This Meeting is the Place to Be:
“The breadth and depth of the presentations was outstanding. There was little repetition whilst remaining entirely on point with respect to the mechanisms underlying aging and longevity. Absolutely outstanding speakers.”
Marilda Chung, Cureline, Inc.
“The quality of presentations and discussions led to a standout, enjoyable experience.”
Rosaly Correa-de-Auraujo, National Institute of Aging
Download the 2024 Event Guide for More Information On:
- Full list of large pharma, fast growing longevity biotechs and investors in attendence
- Invaluable advice on how to achieve investment and partnership from investors actively looking for partnership opportunities
- Full 3-day agenda and scientific content breakdown
- and more!
Other Events in the Series:
